<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-524
Date of Submission: 2024-10-10

This report was submitted by a Pharmacist from Walsh-Hardin Medical Center concerning patient ANON-PX-3319. The subject is an adult other with a significant medical history including asthma, migraines. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Gabapentin (Anticonvulsant) administered via the Intravenous route at a dosage of 14mg, initiated on 2024-08-10 for Neuropathic pain and discontinued on 2024-09-28; Lisinopril (ACE inhibitor) administered via the Intravenous route at a dosage of 470mg, initiated on 2024-08-10 for Hypertension and discontinued on 2024-09-28.

On approximately 2024-09-18, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Stevens-Johnson syndrome, Vomiting, Maculopapular Rash, Pruritus, Nausea. The Stevens-Johnson syndrome was classified as Moderate in severity. This necessitated clinical intervention. The documented action was: Prescribed growth and advised with. The current patient status regarding this symptom is 'Unknown'. The Vomiting was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed moment and advised section. The current patient status regarding this symptom is 'Recovering'. The Maculopapular Rash was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Not Recovered'. The Pruritus was classified as Mild in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Fatal'. The Nausea was classified as Severe in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Not Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Positive rechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: These friend participant soldier firm. Movement as notice join. Staff year common become sit fire beyond PM.</data>
report_id: ADR-2024-524
report_date: '2024-10-10'
patient_details:
  patient_id: ANON-PX-3319
  gender: Other
  relevant_history:
  - asthma
  - migraines
suspected_drugs:
- drug_name: Gabapentin
  dosage: 14mg
  route_of_administration: Intravenous
  start_date: '2024-08-10'
  indication_for_use: Neuropathic pain
  drug_class: Anticonvulsant
  end_date: '2024-09-28'
- drug_name: Lisinopril
  dosage: 470mg
  route_of_administration: Intravenous
  start_date: '2024-08-10'
  indication_for_use: Hypertension
  drug_class: ACE inhibitor
  end_date: '2024-09-28'
adverse_reactions:
- symptom_name: Stevens-Johnson syndrome
  onset_date: '2024-09-18'
  severity: Moderate
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed growth and advised with.
- symptom_name: Vomiting
  onset_date: '2024-09-18'
  severity: Life-threatening
  outcome: Recovering
  intervention_required: true
  intervention_details: Prescribed moment and advised section.
- symptom_name: Maculopapular Rash
  onset_date: '2024-09-18'
  severity: Moderate
  outcome: Not Recovered
  intervention_required: false
- symptom_name: Pruritus
  onset_date: '2024-09-18'
  severity: Mild
  outcome: Fatal
  intervention_required: true
- symptom_name: Nausea
  onset_date: '2024-09-18'
  severity: Severe
  outcome: Not Recovered
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Positive rechallenge
reporting_facility: Walsh-Hardin Medical Center
reporter_type: Pharmacist
notes: These friend participant soldier firm. Movement as notice join. Staff year
  common become sit fire beyond PM.
